Juan Carlos Turriate Gastulo

Array ( [id] => 7232989 [patent_doc_number] => 20050256055 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-11-17 [patent_title] => 'Compounds and methods for reducing undesired toxicity of chemotherapeutic agents' [patent_app_type] => utility [patent_app_number] => 10/843930 [patent_app_country] => US [patent_app_date] => 2004-05-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3908 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0256/20050256055.pdf [firstpage_image] =>[orig_patent_app_number] => 10843930 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 33403 [patent_doc_number] => 07786078 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-08-31 [patent_title] => 'Template-fixed δ-hairpin peptidomimetics with CXCR4 antagonizing activity' [patent_app_type] => utility [patent_app_number] => 10/555088 [patent_app_country] => US [patent_app_date] => 2004-04-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 52453 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/786/07786078.pdf [firstpage_image] =>[orig_patent_app_number] => 10555088 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 968692 [patent_doc_number] => 06939967 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-09-06 [patent_title] => 'Non-proteinogenic L-amino acids' [patent_app_type] => utility [patent_app_number] => 10/833569 [patent_app_country] => US [patent_app_date] => 2004-04-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4532 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/939/06939967.pdf [firstpage_image] =>[orig_patent_app_number] => 10833569 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7422133 [patent_doc_number] => 20040229265 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-11-18 [patent_title] => 'Amino-modified polysaccharides and methods of generating and using same' [patent_app_type] => new [patent_app_number] => 10/831224 [patent_app_country] => US [patent_app_date] => 2004-04-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 25118 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 5 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0229/20040229265.pdf [firstpage_image] =>[orig_patent_app_number] => 10831224 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5733455 [patent_doc_number] => 20060258572 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-16 [patent_title] => 'Somatostatin-dopamine chimeric analogs' [patent_app_type] => utility [patent_app_number] => 10/553014 [patent_app_country] => US [patent_app_date] => 2004-04-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25467 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0258/20060258572.pdf [firstpage_image] =>[orig_patent_app_number] => 10553014 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5205591 [patent_doc_number] => 20070027073 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-02-01 [patent_title] => 'Long-acting derivatives of pyy agonists' [patent_app_type] => utility [patent_app_number] => 10/552591 [patent_app_country] => US [patent_app_date] => 2004-04-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 5719 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0027/20070027073.pdf [firstpage_image] =>[orig_patent_app_number] => 10552591 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7353162 [patent_doc_number] => 20040249121 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-09 [patent_title] => 'Process for production of cyclic peptides' [patent_app_type] => new [patent_app_number] => 10/818246 [patent_app_country] => US [patent_app_date] => 2004-04-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6034 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0249/20040249121.pdf [firstpage_image] =>[orig_patent_app_number] => 10818246 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7155896 [patent_doc_number] => 20050026844 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-02-03 [patent_title] => 'Inhibitors for the soluble epoxide hydrolase' [patent_app_type] => utility [patent_app_number] => 10/817334 [patent_app_country] => US [patent_app_date] => 2004-04-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 25460 [patent_no_of_claims] => 94 [patent_no_of_ind_claims] => 23 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0026/20050026844.pdf [firstpage_image] =>[orig_patent_app_number] => 10817334 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 486712 [patent_doc_number] => 07217794 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-05-15 [patent_title] => 'Compounds and methods for treatment of thrombosis' [patent_app_type] => utility [patent_app_number] => 10/817248 [patent_app_country] => US [patent_app_date] => 2004-04-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 20 [patent_no_of_words] => 53882 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/217/07217794.pdf [firstpage_image] =>[orig_patent_app_number] => 10817248 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7034199 [patent_doc_number] => 20050032709 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-02-10 [patent_title] => 'Anti-hypertensive molecules and process for preparation thereof' [patent_app_type] => utility [patent_app_number] => 10/812831 [patent_app_country] => US [patent_app_date] => 2004-03-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 9748 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0032/20050032709.pdf [firstpage_image] =>[orig_patent_app_number] => 10812831 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7426102 [patent_doc_number] => 20040229777 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-11-18 [patent_title] => 'Crystalline phases of a potent HCV inhibitor' [patent_app_type] => new [patent_app_number] => 10/809597 [patent_app_country] => US [patent_app_date] => 2004-03-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 6840 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 5 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0229/20040229777.pdf [firstpage_image] =>[orig_patent_app_number] => 10809597 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6991389 [patent_doc_number] => 20050090426 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-04-28 [patent_title] => 'Methods of inhibiting inflammation' [patent_app_type] => utility [patent_app_number] => 10/808052 [patent_app_country] => US [patent_app_date] => 2004-03-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 10941 [patent_no_of_claims] => 50 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0090/20050090426.pdf [firstpage_image] =>[orig_patent_app_number] => 10808052 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 558295 [patent_doc_number] => 07157424 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-01-02 [patent_title] => 'Pharmaceutical compositions for hepatitis C viral protease inhibitors' [patent_app_type] => utility [patent_app_number] => 10/807023 [patent_app_country] => US [patent_app_date] => 2004-03-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 8529 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/157/07157424.pdf [firstpage_image] =>[orig_patent_app_number] => 10807023 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 393984 [patent_doc_number] => 07297678 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-11-20 [patent_title] => 'Use of repeat sequence protein polymers in personal care compositions' [patent_app_type] => utility [patent_app_number] => 10/800179 [patent_app_country] => US [patent_app_date] => 2004-03-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 19943 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 77 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/297/07297678.pdf [firstpage_image] =>[orig_patent_app_number] => 10800179 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7168290 [patent_doc_number] => 20050201998 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-15 [patent_title] => 'Novel multipeptide regimen for the treatment of autistic spectrum, behavioral, emotional and visceral inflammation/autoimmune disorders' [patent_app_type] => utility [patent_app_number] => 10/799941 [patent_app_country] => US [patent_app_date] => 2004-03-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 27073 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 17 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0201/20050201998.pdf [firstpage_image] =>[orig_patent_app_number] => 10799941 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7155895 [patent_doc_number] => 20050026843 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-02-03 [patent_title] => 'Organic compounds with biological activity as thrombin inhibitors and use thereof' [patent_app_type] => utility [patent_app_number] => 10/798218 [patent_app_country] => US [patent_app_date] => 2004-03-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12909 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0026/20050026843.pdf [firstpage_image] =>[orig_patent_app_number] => 10798218 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7318865 [patent_doc_number] => 20040224897 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-11-11 [patent_title] => 'Antimircobial peptide and methods of use thereof' [patent_app_type] => new [patent_app_number] => 10/795514 [patent_app_country] => US [patent_app_date] => 2004-03-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 12267 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0224/20040224897.pdf [firstpage_image] =>[orig_patent_app_number] => 10795514 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6958489 [patent_doc_number] => 20050214859 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-29 [patent_title] => 'Peptides that specifically bind HGF receptor (cMet) and uses thereof' [patent_app_type] => utility [patent_app_number] => 10/792582 [patent_app_country] => US [patent_app_date] => 2004-03-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 45691 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0214/20050214859.pdf [firstpage_image] =>[orig_patent_app_number] => 10792582 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7051251 [patent_doc_number] => 20050187138 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-08-25 [patent_title] => 'Peptide beta-strand mimics based on pyridinones, pyrazinones, pyridazinones, and triazinones' [patent_app_type] => utility [patent_app_number] => 10/786615 [patent_app_country] => US [patent_app_date] => 2004-02-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 18132 [patent_no_of_claims] => 169 [patent_no_of_ind_claims] => 35 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0187/20050187138.pdf [firstpage_image] =>[orig_patent_app_number] => 10786615 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 988192 [patent_doc_number] => 06921747 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-07-26 [patent_title] => 'Basic amino acid derivatives' [patent_app_type] => utility [patent_app_number] => 10/777179 [patent_app_country] => US [patent_app_date] => 2004-02-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5340 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/921/06921747.pdf [firstpage_image] =>[orig_patent_app_number] => 10777179 [rel_patent_id] =>[rel_patent_doc_number] =>)